Emergent biosolutions inc

Major-Pharmaceuticals

EBS


400 Professional Drive
Gaithersburg , MD 20879

Executive/
Director

Price

  • Last Close
  • $ 10.17
    $ +1.6 18.67 %
    Aug 29, 2024
  • 52-Week High/Low
  • $12.91 - $1.49
  • YTD
  • 323.8%

  • Trading Volume
  • 52,059
  • Market Cap Full
  • $ 527.7M
  • Shares Outstanding
  • 51.9M
    Dec 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 5.6% -9.2% -11.6% 13.3% -14.8% -5% 3.7% -4.8% -12.2% 5.6%
Q2 14.6% -22.6% 16.8% -0.4% -4.6% 4% -32.2% -25% -29.2% -5.9%
Q3 -13.5% 12.1% 19.3% 26.5% 7.8% 8% -20.5% -32.4% -53.6% -
Q4 40.4% 4.2% 12.5% -9% 7.1% -13.3% -13.2% -43.8% -24.3% -
J F M A M J J A S O N D
2024 -30.2% 92.2% -21.3% -15% - - - - - - - -
2023 11.8% -6.2% -16.3% -14.8% -3.4% -14% -6.3% -31.8% -27.4% -38.6% 2.4% 12.2%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    18%47%-18%42%28%-7%63%-51%-73%-80%324%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.50 0.16 0.29 -0.1 -0.51 -0.24 1.28 -0.07 -3.65
Q2 0.36 0.18 0.13 0.98 -0.18 1.73 0.09 -1.13 -5.15
Q3 0.83 0.58 0.73 0.41 0.83 0.73 -0.61 -1.52 -5.08
Q4 0.78 0.74 0.74 -0.07 0.9 3.45 3.51 -1.75 -
A 2.5 1.7 1.9 1.2 1 5.7 4.3 -4.5 -13.88

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2018 2019 2020 2021 2022 2023
Mar - 51.2 52 53.3 50.5 50.1
Jun 49.8 51.4 52.4 53.6 50.2 50.4
Sep 50 51.6 52.9 53.7 49.9 51.8
Dec 50.9 51.6 53 53.8 49.9 51.9

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 2 2.2 1.7 2 1.6
Fixed Asset Turnover 1.1 2.1 2.1 1.7 1.4
Total Asset Turnover 0.4 0.6 0.5 0.5 0.4
Leverage
Debt Ratio 0.4 0.6 0.7 1.2 1.3
Debt – Equity Ratio 0.3 0.5 0.6 0.7 0.8
Interest Coverage -3.4 2.9 3.4 1.9 3.3
Equity multiplier 0.7 0.5 0.5 0.6 0.6